TRAIL 靶点蛋白|抗体药物|临床药物信息

TRAIL信息

英文名称：Tumor necrosis factor ligand superfamily member 10
中文名称：肿瘤坏死因子配体超家族成员10
靶点别称：CD253，Apo-2 ligand，TNFSF10，TNF Superfamily Member 10，APO2L，Tumor Necrosis Factor Apoptosis-Inducing Ligand Splice Variant Delta，Tumor Necrosis Factor Ligand Superfamily Member 10，Tumor Necrosis Factor (Ligand) Family， Member 10，TNF-Related Apoptosis Inducing Ligand TRAIL，TNF-Related Apoptosis-Inducing Ligand，Tumor Necrosis Factor Ligand 6A，CD253 Antigen，Protein TRAIL，TNLG6A，TL2，TRAIL，Apo-2L，Tumor Necrosis Factor (Ligand) Superfamily， Member 10，Chemokine Tumor Necrosis Factor Ligand Superfamily M

上市药物数量：0
临床药物数量：1
最高研发阶段：临床一期

TRAIL产品列表

筛选结果

产品库

在线 (1)

物种

Human (1)

标签

Mouse IgG Fc Tag (1)

属性

Protein (1)

标记

Unconjugated (1)

货号	物种	产品描述	蛋白结构	纯度	活性
TRL-H5259	Human	Human TRAIL / TNFSF10 Protein, Mouse IgG2a Fc Tag

TRL-H5259|Human TRAIL / TNFSF10 Protein, Mouse IgG2a Fc Tag

188XXXXXXX2

0人赞

应用于ELisa实验，平时放负40℃，反复冻融后，蛋白仍然很稳定，实验误差小，且货期简短，能够满足实验进度需求，好评
2022-08-19

TRAIL 分子别名

Apo-2L,TRAIL,CD253,TNFSF10,Apo-2 ligand

TRAIL 分子背景

TRAIL, also known as TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL, TNLG6A and TNF superfamily member 10. The TRAIL gene as a drug target, induces apoptosis. Its activity may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and TNFRSF11B/OPG that cannot induce apoptosis. TRAIL also binds the receptors DcR1 and DcR2, which do not contain a cytoplasmic domain (DcR1) or contain a truncated death domain (DcR2). DcR1 functions as a TRAIL-neutralizing decoy-receptor. The cytoplasmic domain of DcR2 is functional and activates NFkappaB. In cells expressing DcR2, TRAIL binding therefore activates NFkappaB, leading to transcription of genes known to antagonize the death signaling pathway and/or to promote inflammation.

TRAIL 前沿进展

TRAIL临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
AS-1501	AS-1501	临床一期	深圳市中科艾深医药有限公司	肝功能衰竭, 肝炎, 化学物质和药物引起的慢性肝损伤, 化学及药物性肝损伤, 肝功能衰退	详情

会议日历

会议一览

TRAIL